Alpha Tau Medical Ltd. (DRTSW)Jerusalem, Israel | NasdaqCM
1.00 USD
+0.05
(5.263%)
⇧
(April 17, 2026, 2:07 p.m.
EDT)
Short-term: ★★☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 10:23 p.m. EDT
A deep-value shell offering no income, negative cash flow, and minimal statistical edge despite recent price stability. |
| Attribute | Value |
|---|---|
| Debt to Equity Ratio | 17.803 |
| Beta | 1.05 |
| Website | https://www.alphatau.com |
| Attribute | Value |
|---|---|
| Address1 | Kiryat HaMada St. 5 |
| Ask | 0.0 |
| Ask Size | 0 |
| Beta | 1.046 |
| Bid | 0.0 |
| Bid Size | 0 |
| Book Value | 0.876 |
| City | Jerusalem |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | Israel |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.0 |
| Current Ratio | 7.452 |
| Custom Price Alert Confidence | HIGH |
| Day High | 1.03 |
| Day Low | 0.945 |
| Debt To Equity | 17.803 |
| Display Name | Alpha Tau Medical |
| Ebitda | -41,056,000 |
| Ebitda Margins | 0.0 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Two Week High | 1.03 |
| Fifty Two Week High Change | -0.029999971 |
| Fifty Two Week High Change Percent | -0.029126186 |
| Fifty Two Week Low | 0.945 |
| Fifty Two Week Low Change | 0.055000007 |
| Fifty Two Week Low Change Percent | 0.058201067 |
| Fifty Two Week Range | 0.945 - 1.03 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,772,807,400,000 |
| Float Shares | 45,316,214 |
| Free Cashflow | -19,703,876 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 121 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Industry | |
| Industry Key | |
| Ipo Expected Date | 2,022-03-08 |
| Language | en-US |
| Long Business Summary | Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company is headquartered in Jerusalem, Israel. |
| Long Name | Alpha Tau Medical Ltd. |
| Market | us_market |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_531816986 |
| Net Income To Common | -42,627,000 |
| Open | 0.3251 |
| Operating Cashflow | -26,681,000 |
| Operating Margins | 0.0 |
| Phone | 972 3 577 4115 |
| Previous Close | 0.95 |
| Price Hint | 4 |
| Price To Book | 1.1415526 |
| Profit Margins | 0.0 |
| Quick Ratio | 6.992 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.050000012 |
| Regular Market Change Percent | 5.2631593 |
| Regular Market Day High | 1.03 |
| Regular Market Day Low | 0.945 |
| Regular Market Day Range | 0.945 - 1.03 |
| Regular Market Open | 0.3251 |
| Regular Market Previous Close | 0.95 |
| Regular Market Price | 1.0 |
| Regular Market Time | 1,776,449,278 |
| Regular Market Volume | 35,710 |
| Return On Assets | -0.27552 |
| Return On Equity | -0.60998 |
| Sand P52 Week Change | 0.38150132 |
| Sector | |
| Sector Key | |
| Short Name | Alpha Tau Medical Ltd. Warrant |
| Source Interval | 15 |
| Symbol | DRTSW |
| Total Cash | 73,126,000 |
| Total Cash Per Share | 0.831 |
| Total Debt | 13,726,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Type Disp | Equity |
| Volume | 35,710 |
| Website | https://www.alphatau.com |
| Zip | 9,777,605 |